Intracardiac thrombi on transvenous leads are found incidentally in 1.4% to 30% of cases, with management strategies varying widely across case reports.
Variable lead thrombus prevalence warrants individualized evaluation; leaves open optimal management without prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jorgensen et al. (2024) conducted a review in Intracardiac thrombi on transvenous leads. Management strategies (surgical embolectomy, mechanical thrombectomy, thrombolysis, lead removal, anticoagulation) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: